Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000004

Director sold 78,693 shares at an average $30.08 ($2,367,473)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Booth Bruce Director 2025-09-29 Sale 10b5-1 −54,637 $30.09 $1,644,027 2,831,656 I
Booth Bruce Director 2025-09-29 Sale 10b5-1 −11,468 $30.09 $345,072 796,259 I
Booth Bruce Director 2025-09-30 Sale 10b5-1 −10,239 $30.06 $307,784 2,821,417 I
Booth Bruce Director 2025-09-30 Sale 10b5-1 −2,149 $30.06 $64,599 794,110 I
Booth Bruce Director 2025-10-01 Sale 10b5-1 −165 $29.95 $4,942 2,821,252 I
Booth Bruce Director 2025-10-01 Sale 10b5-1 −35 $29.95 $1,048 794,075 I
Open-market sales · 78,693 sh · avg $30.08 · $2,367,473
Loading xslF345X05/form4-10012025_101039.xml…